NEWS and OPINIONS
What’s next for lab-grown human embryos?
Researchers are now permitted to grow human embryos in the lab for longer than 14 days. Here’s what they could learn. By Kendall Powell - Nature - August 31, 2021 (link to original article) It was day 13 in a set of experiments in Ali Brivanlou’s laboratory and he...
New Hope for Muscle-Related Diseases? Converting skin cells to immature muscle cells spurs changes, study finds
By TRACY HAMPTON | MGH News & Public Affairs August 25, 2021 - Investigators who previously developed a recipe for turning skin cells into primitive, musclelike cells that can be maintained indefinitely in the lab without losing the potential to become mature...
Scientists develop brain organoids with complex neural activity
UCLA study suggests researchers could analyze neurological disorders in a stem cell–derived model By Sarah C.P. Williams August 23, 2021 - Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed brain...
Phase 1 clinical study reveals how stem cells alleviate COPD inflammation in humans
Durham, NC (August 18, 2021) – A new phase I clinical study shows, for the first time, how treatment with a type of stem cell called mesenchymal stromal cells is able to regulate important factors driving inflammation in patients with chronic obstructive pulmonary...
Volunteers bring “tears of joy” to paralyzed resident by making Miami Beach accessible to all
CLICK HERE TO WATCH streaming video on CBS NEWS Miami Beach, Florida - CBS Evening News — For Sergio Echeverria, it wasn't just a day at the beach. Nicknamed Aquaman, Echeverria has always considered the ocean to be his second home — but a tractor accident this winter...
UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
PITTSBURGH, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A new collaboration among UPMC Hillman Cancer Center, the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ: AVCO) aims to develop new cancer immunotherapy approaches and...
The Tennessee Institute of Regenerative Medicine Gains International Reach With New Partnership
Written by Lee Ferguson - link to original news article July 27, 2021 - An institute led by the University of Tennessee Health Science Center is gaining international reach, thanks to a new partnership with a worldwide interdisciplinary network. The Tennessee...
National Survey IDs Gaps and Opportunities for Regenerative Medicine Workforce
WINSTON-SALEM, NC, July 15, 2021 - (Link to EurekAlert Article) Answering a charge from the National Science Board, the RegenMed Development Organization (ReMDO), through its RegeneratOR Workforce Development Initiative, has released the results of a national survey...
The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age
By: William A. Haseltine - Forbes.com - link to Article IMAGE CAPTION - 3D printed organ scaffolds by Wake Forest Institute for Regenerative Medicine is displayed as part of the 'AI: More than Human' exhibition at the Barbican Curve Gallery on May 15, 2019 in London,...
The Memphis Institute of Regenerative Medicine Rebrands To Reflect Statewide Reach
Written by Lee Ferguson July 13, 2021 - A cutting-edge University of Tennessee Health Science Center institute, the Memphis Institute of Regenerative Medicine, is rebranding to reflect its growing reach across the state. Effective this month, it will be known as the...
ISS National Lab to Host Session at World Stem Cell Summit on Regenerative Medicine in Low Earth Orbit
The International Space Station (ISS) U.S. National Laboratory will host a panel of industry experts on the impacts of health, aging, and human survival research onboard the orbiting laboratory at the World Stem Cell Summit. This annual event brings together noted...
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (“off-the-shelf”) CAR-T and CAR-γδT cell therapy candidates targeting hematologic malignancies and solid tumors SenlangBio’s lead CAR-T...